BACKGROUND: Dyslipidemia has been identified as a risk factor for the development and progression of diabetic renal disease. OBJECTIVE: This study was done to determine the prevalence of dyslipidemia among diabetic patients with overt nephropathy. MATERIALS AND METHODS: A total of 72 diabetic patients with overt diabetic nephropathy and 36 age- and sex-matched normoalbuminuric diabetic patients were studied. Their fasting lipid profile, fasting blood sugar, and renal function tests were evaluated. RESULTS: Total serum cholesterol and serum triglycerides were significantly higher in patients with overt diabetic nephropathy compared to the controls; 66.7% and 62.5% versus 36.1% and 30.6%, respectively ( P = 0.003 and 0.002, respectively). CONCLUSIONS: Diabetic patients with overt diabetic nephropathy have significant dyslipidemia and aggressive lipid lowering in these patients may retard their progression to end-stage renal disease.
BACKGROUND:Dyslipidemia has been identified as a risk factor for the development and progression of diabetic renal disease. OBJECTIVE: This study was done to determine the prevalence of dyslipidemia among diabeticpatients with overt nephropathy. MATERIALS AND METHODS: A total of 72 diabeticpatients with overt diabetic nephropathy and 36 age- and sex-matched normoalbuminuric diabeticpatients were studied. Their fasting lipid profile, fasting blood sugar, and renal function tests were evaluated. RESULTS: Total serum cholesterol and serum triglycerides were significantly higher in patients with overt diabetic nephropathy compared to the controls; 66.7% and 62.5% versus 36.1% and 30.6%, respectively ( P = 0.003 and 0.002, respectively). CONCLUSIONS:Diabeticpatients with overt diabetic nephropathy have significant dyslipidemia and aggressive lipid lowering in these patients may retard their progression to end-stage renal disease.
Authors: Sylvester Yao Lokpo; Roger Laryea; James Osei-Yeboah; William K B A Owiredu; Richard K D Ephraim; Esther Ngozi Adejumo; Samuel Ametepe; Michael Appiah; Nogo Peter; Patrick Affrim; Precious Kwablah Kwadzokpui; Ohene Kweku Abeka Journal: Heliyon Date: 2022-08-17